1. Artificial Intelligence and Cancer Control: Toward Prioritizing Justice, Equity, Diversity, and Inclusion (JEDI) in Emerging Decision Support Technologies

   • Peter Taber
   • Julie S. Armin
   • Sonoo Thadaney Israni

   ReviewPaper 22 February 2023 Pages: 387 - 424

   

2. An Update in Anticoagulant Therapy for Patients with Cancer-Associated Venous Thromboembolism

   • Murillo A. Martins
   • Taysa F. Silva
   • Caio J. Fernandes

   ReviewPaper 16 March 2023 Pages: 425 - 432

   

3. Cardiovascular Toxicity and Risk Mitigation with Lung Cancer Treatment

   • Nikhil Yegya-Raman
   • Eva Berlin
   • Lova Sun

   ReviewPaper 22 February 2023 Pages: 433 - 444

4. Cardiovascular Risks in Testicular Cancer: Assessment, Prevention, and Treatment

   • Suparna C. Clasen
   • Chunkit Fung
   • Lois B. Travis

   ReviewPaper 03 March 2023 Pages: 445 - 454

   

5. Clonal Hematopoiesis and the Heart: a Toxic Relationship

   • Jeffrey L. Jensen
   • Saumya Easaw
   • Catherine C. Coombs

   ReviewPaper 15 March 2023 Pages: 455 - 463

   

6. Integrating Functional Imaging and Molecular Profiling for Optimal Treatment Selection in Neuroendocrine Neoplasms (NEN)

   • Grace Kong
   • Emma Boehm
   • Michael Michael

   ReviewPaper Open access 24 February 2023 Pages: 465 - 478

   

7. CAR-T Therapies in Solid Tumors: Opportunities and Challenges

   • Grace Guzman
   • Megan R. Reed
   • Analiz Rodriguez

   ReviewPaper Open access 28 February 2023 Pages: 479 - 489

   

8. Molecular Profiling in Early ER + Breast Cancer to Aid Systemic Therapy Decisions

   • Oleg Gluz
   • Monika Graeser

   ReviewPaper 02 March 2023 Pages: 491 - 500

   

9. Management of Recurrent HPV-Positive Oropharyngeal Squamous Cell Carcinoma: a Contemporary Review

   • Sam Dowthwaite
   • James Jackson
   • Emily Guazzo

   ReviewPaper 07 March 2023 Pages: 501 - 510

   

10. Current Status of Perioperative Therapy in Muscle-Invasive Bladder Cancer and Future Directions

    • Dillon C. Cockrell
    • Tracy L. Rose

    ReviewPaper 10 March 2023 Pages: 511 - 520

    

11. AXL Inhibitors: Status of Clinical Development

    • Sheena Bhalla
    • David E. Gerber

    ReviewPaper 15 March 2023 Pages: 521 - 529

    

12. Advances in Targeted Therapy for Neurofibromatosis Type 2 (NF2)-Associated Vestibular Schwannomas

    • Evan C. Cumpston
    • Steven D. Rhodes
    • Charles W. Yates

    ReviewPaper 18 March 2023 Pages: 531 - 537